 |
|
Giving an additional early vaccination may reduce measles outbreaks
July 25, 2008Research paper: Protective efficacy of standard Edmonston-Zagreb vaccination in infants aged 4.5 months: Randomized controlled trial
Outbreaks of measles in developing countries may be reduced by vaccinating infants at 4.5 months of age as well as at the World Health Organization's recommended routine vaccination at 9 months, according to a study published on BMJ.com today.
These findings should lead to reconsideration of the policy for vaccination during measles outbreaks and in humanitarian emergencies, say the authors.
Maternal antibodies protect against measles during the first months of life and infants routinely receive their first vaccination between 9 and 15 months to coincide with when these maternal antibodies are lost. This vaccination policy was based on children born to naturally infected mothers, but measles vaccination campaigns over the past 20-25 years in low income countries have resulted in many mothers being immunised and transferring only half the maternal measles antibodies as naturally immune mothers.
Similarly, HIV positive mothers transfer a smaller number of antibodies than HIV negative mothers and HIV positive children also lose their protective maternal antibodies early. As a result, a new group of children now exist who may lose their protection by 3 to 5 months of age and there may well be a need to provide measles vaccination at an earlier age.
A measles outbreak in Guinea-Bissau in Africa offered Professor Peter Aaby and colleagues a unique opportunity to assess the protective effect of earlier vaccination at 4.5 months. 1333 infants were randomised to receive either measles vaccination at 4.5 months of age (441) or nothing (892). At 9 months of age all children received a measles vaccination. Blood samples were collected to assess levels of maternal antibodies levels against measles at 4.5, 9, and 24 months of age in the early vaccination group and at 9, 18, and 24 months of age in the control group.
The researchers found that early vaccination at 4.5 months of age offered more than 90% protection against measles infection and 100% protection against measles hospitalisation.
Prior to the initial vaccination at 4.5 months of age only 28% of the children had protective levels of maternal antibodies against measles. After this early vaccination 92% had measles antibodies at 9 months of age.
The researchers found that children vaccinated at 4.5 months and 9 months were better protected than those vaccinated only at 9 months. The monthly incidence of measles was 0.7% in the children who received two doses and 3.1% in the children who received one dose at 9 months.
"If elimination of measles is planned it will be necessary in Africa to immunise as early as possible for many years", conclude the authors.
These findings offer policymakers potential alternative vaccination strategies, but research is required to determine the possible immunosuppressive effect from live virus measles vaccines on other vaccine responses when given in early infancy, say Dr Hélène Broutin and Dr Mark A Miller from the National Institutes of Health, in an accompanying editorial.
"The current goal to achieve high vaccine coverage should not be separated from the need for more timely vaccination, especially in developing countries-[but] earlier measles vaccination should not substitute for the dose given to infants at ages 9-15 months, which increases overall immunity in the population", they conclude.
BMJ-British Medical Journal
Maternal antibodies protect against measles during the first months of life and infants routinely receive their first vaccination between 9 and 15 months to coincide with when these maternal antibodies are lost. This vaccination policy was based on children born to naturally infected mothers, but measles vaccination campaigns over the past 20-25 years in low income countries have resulted in many mothers being immunised and transferring only half the maternal measles antibodies as naturally immune mothers.
Similarly, HIV positive mothers transfer a smaller number of antibodies than HIV negative mothers and HIV positive children also lose their protective maternal antibodies early. As a result, a new group of children now exist who may lose their protection by 3 to 5 months of age and there may well be a need to provide measles vaccination at an earlier age.
A measles outbreak in Guinea-Bissau in Africa offered Professor Peter Aaby and colleagues a unique opportunity to assess the protective effect of earlier vaccination at 4.5 months. 1333 infants were randomised to receive either measles vaccination at 4.5 months of age (441) or nothing (892). At 9 months of age all children received a measles vaccination. Blood samples were collected to assess levels of maternal antibodies levels against measles at 4.5, 9, and 24 months of age in the early vaccination group and at 9, 18, and 24 months of age in the control group.
The researchers found that early vaccination at 4.5 months of age offered more than 90% protection against measles infection and 100% protection against measles hospitalisation.
Prior to the initial vaccination at 4.5 months of age only 28% of the children had protective levels of maternal antibodies against measles. After this early vaccination 92% had measles antibodies at 9 months of age.
The researchers found that children vaccinated at 4.5 months and 9 months were better protected than those vaccinated only at 9 months. The monthly incidence of measles was 0.7% in the children who received two doses and 3.1% in the children who received one dose at 9 months.
"If elimination of measles is planned it will be necessary in Africa to immunise as early as possible for many years", conclude the authors.
These findings offer policymakers potential alternative vaccination strategies, but research is required to determine the possible immunosuppressive effect from live virus measles vaccines on other vaccine responses when given in early infancy, say Dr Hélène Broutin and Dr Mark A Miller from the National Institutes of Health, in an accompanying editorial.
"The current goal to achieve high vaccine coverage should not be separated from the need for more timely vaccination, especially in developing countries-[but] earlier measles vaccination should not substitute for the dose given to infants at ages 9-15 months, which increases overall immunity in the population", they conclude.
BMJ-British Medical Journal
Measles Vaccination Current Events and Measles Vaccination News RSSKenyan malaria success strengthens call for free insecticide-treated nets for all
Experts have today called for international agencies to provide insecticide-treated bed nets for all children in Africa as the most equitable way of tackling malaria.
Studies affirm need for influenza and measles vaccinations in HIV-infected patients
Two new studies emphasize the importance of delivering measles and influenza vaccines to HIV-infected individuals. Both studies are published in the August 1 issue of The Journal of Infectious Diseases, now available online.
Measles Vaccinations Need to be Repeated to Protect HIV-Infected Children
HIV-infected children may require repeat measles vaccination for protection, according to new research from the Johns Hopkins Bloomberg School of Public Health and other institutions.
Study supports whooping cough booster shot for adolescents
Despite childhood vaccination rates at all-time highs, pertussis (whooping cough) has re-emerged over the past two decades, especially among adolescents, adults, and young infants. Because of this resurgence, federal health policymakers are considering a national booster vaccination program.
New Research Highlights How Six Million Child Deaths Worldwide Could Be Avoided Every Year
Leading public-health scientists are calling for urgent action to end a global public-health disaster--that of the fate of more than 10 million children worldwide under five years of age who die every year. The key finding in a series of five articles to be published in THE LANCET over the next month is that two-thirds of these child deaths could be prevented with existing knowledge and known treatments for the main causes of childhood death: diarrhoeal disease, malaria, pneumonia, and neonatal causes. Authors of the series are issuing an urgent call to action--prioritising the need for global leadership and increased resources--to ensure that child survival becomes a key priority for govern
No evidence that MMR vaccine is associated with autism or bowel disease
There is no evidence that MMR or single measles vaccines are associated with autism or inflammatory bowel disease, researchers announced today. Their conclusion follows the most in-depth analysis of the scientific literature to date, and provides clear reassurance for parents and health professionals regarding the safety of MMR vaccination. Their findings will be published in Clinical Evidence, the international source of the best available evidence for effective health care, published by the BMJ Publishing Group. Dr Anna Donald, Dr Vivek Muthu and the information scientists at Clinical Evidence have conducted a detailed search of the world's scientific literature on MMR and single measles v
SUCCESSFUL MEASLES VACCINATION FEASIBLE IN LOW-INCOME COUNTRIES (p 1564)
Results of a study in this week's issue of THE LANCET highlight the success of a WHO-recommended measles elimination strategy in southern Africa. Authors of the study emphasise how such strategies can substantially reduce illness and death from measles, the most contagious disease known to man. Globally, although national immunisation programmes are estimated to prevent 80 million cases and 4. 5million deaths due to measles yearly, it is estimated that more than 30 million cases and 0.9 million deaths still occur every year; around half of these deaths occur in Africa. In southern Africa from 1996, seven countries with a total population of around 70 million (Botswana, Lesotho, Malawi, Nami
REFUGEE SERIES - 50 YEARS ON (pp 1384, 1425-37, 1454)
Half a century after the adoption of the 1951 Convention relating to the Status of Refugees, THE LANCET is this week publishing a series of thought-provoking articles concerning the health and human rights of the world's population of displaced people. The series of essays discusses a wide range of refugee issues in both less-developed and more-developed settings. Topics covered include fundamental aspects such as the need to redefine refugee status; internally displaced persons (IDPs), for example, now outnumber refugees (21 million worldwide compared with 14 million, respectively). IDPs, however, forced by civil conflict to move to other parts of their mother country, are not protected by
More Measles Vaccination Current Events and Measles Vaccination News Articles
| Childhood vaccination rates high, but measles re-emerging.: An article from: The Nation's Health by Gale Reference Team This digital document is an article from The Nation's Health, published by The Nation's Health on November 1, 2008. The length of the article is 701 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Childhood vaccination rates high,... | |
| Estimation of measles vaccination coverage using the Lot Quality Assurance Sampling (LQAS) method--Tamilnadu, India, 2002-2003. : An article from: Morbidity and Mortality Weekly Report by Saravanan Sivasankaran, P. Manickam, R. Ramakrishnan, Y. Hutin, M.D. Gupte This digital document is an article from Morbidity and Mortality Weekly Report, published by Thomson Gale on April 28, 2006. The length of the article is 2577 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Nationwide measles vaccination campaign for children aged 6 months-12 years--Afghanistan, 2002.: An article from: Morbidity and Mortality Weekly Report This digital document is an article from Morbidity and Mortality Weekly Report, published by U.S. Government Printing Office on April 25, 2003. The length of the article is 1877 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
| Infant-measles wave traced to 1960s vaccinations. (childhood vaccination causes failure of mothers to pass measles resistance to infants) (Vaccination News): An article from: Special Delivery This digital document is an article from Special Delivery, published by Association of Labor Assistants & Childbirth Educators on December 22, 1992. The length of the article is 491 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any... | |
| Measles in not your ordinary childhood disease. (importance of measles vaccination to prevent deadly epidemics): An article from: Medical Update This digital document is an article from Medical Update, published by Benjamin Franklin Literary & Medical Society, Inc. on May 1, 1991. The length of the article is 762 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
 | RAISING A VACCINE FREE CHILD by Wendy Lydall This book provides parents with a comprehensive, scientifically-based guide to the facts, myths, problems and solutions associated with raising a vaccine free child. It helps parents protect their children both from the wiles of the vaccine industry and from harmful germs. With 471 references, there are no trendy anti-vaccination myths in this book. Readers will learn that immunisation is not the... |
| U.S. Declares Indigenous Measles Eliminated.(Brief Article): An article from: Family Practice News by Bruce Jancin This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 1999. The length of the article is 756 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| A benefit-cost analysis of measles vaccinations in Yaounde, Cameroon (Discussion paper / Center for Research on Economic Development) by William Martin Makinen | |
| Evaluation of the Young Child Protection Programme in Tanzania: A preliminary report focussing on measles vaccination by M. P Mandara | |
| Jamaica's measles elimination experience by Jon Mark Hirshon |
| © 2009 BrightSurf.com |